Free Trial
NASDAQ:ASLN

ASLAN Pharmaceuticals (ASLN) Stock Price, News & Analysis

ASLAN Pharmaceuticals logo
$0.60 0.00 (0.00%)
As of 07/8/2025

About ASLAN Pharmaceuticals Stock (NASDAQ:ASLN)

Key Stats

Today's Range
$0.60
$0.60
50-Day Range
$0.60
$0.60
52-Week Range
$0.48
$25.44
Volume
N/A
Average Volume
122,322 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ASLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ASLN Stock News Headlines

Banks aren’t ready for this altcoin—are you?
The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
See More Headlines

ASLN Stock Analysis - Frequently Asked Questions

ASLAN Pharmaceuticals' stock was trading at $0.60 at the start of the year. Since then, ASLN shares have increased by 0.0% and is now trading at $0.60.

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) posted its quarterly earnings results on Friday, August, 11th. The company reported ($0.88) earnings per share (EPS) for the quarter, topping the consensus estimate of ($6.40) by $5.52. The company earned $12 million during the quarter.

ASLAN Pharmaceuticals shares reverse split before market open on Wednesday, July 3rd 2024.The 1-8 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

ASLAN Pharmaceuticals (ASLN) raised $60 million in an IPO on Friday, May 4th 2018. The company issued 7,500,000 shares at a price of $8.05 per share. Leerink Partners and Piper Jaffray acted as the underwriters for the IPO and BTIG, H.C. Wainwright and CLSA were co-managers.

Shares of ASLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ASLAN Pharmaceuticals investors own include Tesla (TSLA), Sorrento Therapeutics (SRNE), Bionano Genomics (BNGO), Meta Platforms (META), Zoom Communications (ZM), Fulgent Genetics (FLGT) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
8/11/2023
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASLN
CIK
1722926
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($21.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.22 million
Net Margins
N/A
Pretax Margin
-290.83%
Return on Equity
-8,454.87%
Return on Assets
-121.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
1.05

Sales & Book Value

Annual Sales
$12 million
Price / Sales
0.10
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($6.50) per share
Price / Book
-0.09

Miscellaneous

Outstanding Shares
2,044,000
Free Float
1,948,000
Market Cap
$1.23 million
Optionable
Optionable
Beta
1.40
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ASLN) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners